Viewing Study NCT01813461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2026-01-12 @ 9:17 AM
Study NCT ID: NCT01813461
Status: COMPLETED
Last Update Posted: 2013-03-19
First Post: 2013-03-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects
Sponsor: Astellas Pharma Global Development, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetics of 14C-labeled Isavuconazole View
None Healthy Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BAL8557 View
None 14C-labeled isavuconazole View
None 14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate) View